Alfred Morgenstern

3.8k total citations
103 papers, 2.9k citations indexed

About

Alfred Morgenstern is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Alfred Morgenstern has authored 103 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Radiology, Nuclear Medicine and Imaging, 38 papers in Pulmonary and Respiratory Medicine and 21 papers in Oncology. Recurrent topics in Alfred Morgenstern's work include Radiopharmaceutical Chemistry and Applications (80 papers), Medical Imaging Techniques and Applications (30 papers) and Prostate Cancer Treatment and Research (15 papers). Alfred Morgenstern is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (80 papers), Medical Imaging Techniques and Applications (30 papers) and Prostate Cancer Treatment and Research (15 papers). Alfred Morgenstern collaborates with scholars based in Germany, Belgium and United States. Alfred Morgenstern's co-authors include Frank Bruchertseifer, Christos Apostolidis, R. Molinet, Gert Rasmussen, Clemens Kratochwil, Uwe Haberkorn, Frederik L. Giesel, Antonia G. Denkova, Barry Allen and Hendrik Rathke and has published in prestigious journals such as Blood, PLoS ONE and Analytical Chemistry.

In The Last Decade

Alfred Morgenstern

100 papers receiving 2.9k citations

Peers

Countries citing papers authored by Alfred Morgenstern

Since Specialization

Citations

This map shows the geographic impact of Alfred Morgenstern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfred Morgenstern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfred Morgenstern more than expected).

Fields of papers citing papers by Alfred Morgenstern

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfred Morgenstern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfred Morgenstern. The network helps show where Alfred Morgenstern may publish in the future.

Co-authorship network of co-authors of Alfred Morgenstern

This figure shows the co-authorship network connecting the top 25 collaborators of Alfred Morgenstern. A scholar is included among the top collaborators of Alfred Morgenstern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfred Morgenstern. Alfred Morgenstern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In vitro and in vivo evaluation of anti-HER2 antibody conjugates labelled with 225Ac 2025 ·EJNMMI Radiopharmacy and Chemistry ·(unknown), (unknown), Martin Vlk, Ján Kozempel, (unknown), Zbyněk Nový, (unknown), Marián Hajdúch, Miloš Petřík, Marek Pruszyński, Frank Bruchertseifer, Alfred Morgenstern	0
2	Development of 225Ac/213Bi generator based on α-ZrP-PAN composite for targeted alpha therapy 2024 ·Nuclear Medicine and Biology ·(unknown), (unknown), (unknown), Martin Vlk, Frank Bruchertseifer, Alfred Morgenstern, Ján Kozempel	3
3	225Ac-PSMA-617 radioligand therapy of de novo metastatic hormone-sensitive prostate carcinoma (mHSPC): preliminary clinical findings 2023 ·European Journal of Nuclear Medicine and Molecular Imaging ·Mike Sathekge, Frank Bruchertseifer, Mariza Vorster, Ismaheel O. Lawal, Kgomotso Mokoala, (unknown), (unknown), Honest Ndlovu, (unknown), Alex Maes, Alfred Morgenstern, Christophe Van de Wiele	31
4	Long-Term Tumor Control Following Targeted Alpha Therapy (TAT) of Low-Grade Gliomas (LGGs): A New Treatment Paradigm? 2023 ·International Journal of Molecular Sciences ·Leszek Królicki, Jolanta Kunikowska, Dominik Cordier, Nedelina Slavova, Henryk Koziara, Frank Bruchertseifer, Helmut R. Maëcke, Alfred Morgenstern, Adrian Merlo	3
5	α-Zirconium(IV) Phosphate: Static Study of 225Ac Sorption in an Acidic Environment and Its Kinetic Sorption Study Using natEu as a Model System for 225Ac 2023 ·Materials ·(unknown), (unknown), Martin Vlk, K. Štamberg, Frank Bruchertseifer, Alfred Morgenstern, Ján Kozempel	2
6	Preclinical Evaluation of 225Ac-Labeled Single-Domain Antibody for the Treatment of HER2pos Cancer 2022 ·Molecular Cancer Therapeutics ·(unknown), Yana Dekempeneer, Maria Wojewódzka, Vicky Caveliers, Peter Covens, Brian W. Miller, (unknown), Frank Bruchertseifer, Alfred Morgenstern, Tony Lahoutte, Matthias D’Huyvetter, Marek Pruszyński	20
7	Hematologic toxicity profile and efficacy of [225Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer 2022 ·European Journal of Nuclear Medicine and Molecular Imaging ·Ismaheel O. Lawal, Alfred Morgenstern, Mariza Vorster, Otto Knoesen, Johncy Mahapane, (unknown), (unknown), Honest Ndlovu, (unknown), Gbenga O. Popoola, Kgomotso Mokoala, (unknown), Frank Bruchertseifer, Mike Sathekge	38
8	Towards ²¹³Bi alpha-therapeutics and beyond: unravelling the foundations of efficient Bi^III complexation by DOTP 2021 ·Inorganic Chemistry Frontiers ·(unknown), (unknown), (unknown), (unknown), Gyula Tircsó, Imre Tóth, Frank Bruchertseifer, Alfred Morgenstern, Johannes Notni, Giovanni B. Giovenzana, Zsolt Baranyai	13
9	An octadentate bis(semicarbazone) macrocycle: a potential chelator for lead and bismuth radiopharmaceuticals 2020 ·Dalton Transactions ·(unknown), (unknown), Michelle Ma, Jonathan M. White, Alfred Morgenstern, Frank Bruchertseifer, Philip J. Blower, Brett M. Paterson	18
10	Therapeutic Efficacy of ²¹³Bi-labeled sdAbs in a Preclinical Model of Ovarian Cancer 2020 ·Molecular Pharmaceutics ·Yana Dekempeneer, Vicky Caveliers, Maarten Ooms, (unknown), (unknown), Tony Lahoutte, Catarina Xavier, Quentin Lecocq, Ken Maes, Peter Covens, Brian W. Miller, Frank Bruchertseifer, Alfred Morgenstern, Thomas Cardinaels, Matthias D’Huyvetter	45
11	The in vivo fate of 225Ac daughter nuclides using polymersomes as a model carrier 2019 ·Scientific Reports ·Robin M. de Kruijff, René Raavé, Annemarie Kip, Janneke D.M. Molkenboer‐Kuenen, Alfred Morgenstern, Frank Bruchertseifer, Sandra Heskamp, Antonia G. Denkova	62
12	Structure-function analysis and therapeutic efficacy of antibodies to fungal melanin for melanoma radioimmunotherapy 2018 ·Scientific Reports ·Joshua D. Nosanchuk, (unknown), Anandhi Ray, Ekaterina Revskaya, Zewei Jiang, Ruth Bryan, Kevin J. Allen, (unknown), Mackenzie E. Malo, Beatriz L. Gómez, Alfred Morgenstern, Frank Bruchertseifer, David Rickles, George B. Thornton, Anthony Bowen, Arturo Casadevall, Ekaterina Dadachova	23
13	The therapeutic potential of polymersomes loaded with 225Ac evaluated in 2D and 3D in vitro glioma models 2018 ·European Journal of Pharmaceutics and Biopharmaceutics ·Robin M. de Kruijff, Astrid J.G.M. van der Meer, (unknown), (unknown), Alfred Morgenstern, Frank Bruchertseifer, Peter Sminia, Antonia G. Denkova	31
14	A Radiolabeled Fully Human Antibody to Human Aspartyl (Asparaginyl) β -Hydroxylase Is a Promising Agent for Imaging and Therapy of Metastatic Breast Cancer 2017 ·Cancer Biotherapy and Radiopharmaceuticals ·Ekaterina Revskaya, Zewei Jiang, Alfred Morgenstern, Frank Bruchertseifer, (unknown), Susan Walker, Steven A. Fuller, Michael Lebowitz, Claudia Gravekamp, Hossein Ghanbari, Ekaterina Dadachova	10
15	In Vitro comparison of 213Bi- and 177Lu-radiation for peptide receptor radionuclide therapy 2017 ·PLoS ONE ·Ho Sze Chan, Erik de Blois, Alfred Morgenstern, Frank Bruchertseifer, Marion de Jong, Wouter A.P. Breeman, Mark Konijnenberg	38
16	Preventing Radiobleaching of Cyanine Fluorophores Enhances Stability of Nuclear/NIRF Multimodality Imaging Agents 2016 ·Theranostics ·Reinier Hernandez, Sandra Heskamp, Mark Rijpkema, Desirée L. Bos, David M. Goldenberg, William J. McBride, Alfred Morgenstern, Frank Bruchertseifer, Weibo Cai, Otto C. Boerman	23
17	Utilizing High-Energy γ-Photons for High-Resolution ²¹³Bi SPECT in Mice 2015 ·Journal of Nuclear Medicine ·(unknown), Ho Sze Chan, Marlies C Goorden, Alfred Morgenstern, Frank Bruchertseifer, Freek J. Beekman, Marion de Jong, Mark Konijnenberg	31
18	213Bi-anti-EGFR radioimmunoconjugates and X-ray irradiation trigger different cell death pathways in squamous cell carcinoma cells 2013 ·Nuclear Medicine and Biology ·Anja Pickhard, Guido Piontek, Christof Seidl, (unknown), Birgit Blechert, (unknown), Gero Brockhoff, Frank Bruchertseifer, Alfred Morgenstern, Markus Essler	7
19	Measurements of the half-life of 214Po and 218Rn using digital electronics 2012 ·Applied Radiation and Isotopes ·G. Suliman, S. Pommé, M. Marouli, R. Van Ammel, Viktor Jobbágy, J. Paepen, H. Stroh, Christos Apostolidis, K. Abbas, Alfred Morgenstern	23
20	Comparison of therapeutic efficacy and biodistribution of 213Bi- and 211At-labeled monoclonal antibody MX35 in an ovarian cancer model 2011 ·Nuclear Medicine and Biology ·(unknown), Tom Bäck, Jörgen Elgqvist, Lars Jacobsson, Ragnar Hultborn, Per Albertsson, Alfred Morgenstern, Frank Bruchertseifer, Holger Jensen, Sture Lindegren	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact